dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Piñana, José Luis |
dc.contributor.author | Martino, Rodrigo |
dc.contributor.author | García‑García, Irene |
dc.contributor.author | Parody, Rocío |
dc.contributor.author | Morales, María Dolores |
dc.contributor.author | Benzo, Gonzalo |
dc.contributor.author | Fox, Maria Laura |
dc.date.accessioned | 2021-10-22T09:08:50Z |
dc.date.available | 2021-10-22T09:08:50Z |
dc.date.issued | 2020-08-25 |
dc.identifier.citation | Piñana JL, Martino R, García-García I, Parody R, Morales MD, Benzo G, et al. Risk factors and outcome of COVID-19 in patients with hematological malignancies. Exp Hematol Oncol. 2020 Aug 25;9:21. |
dc.identifier.issn | 2162-3619 |
dc.identifier.uri | https://hdl.handle.net/11351/6447 |
dc.description | Neoplàsies hematològiques; Factors de risc; Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV |
dc.description.sponsorship | This study has not been funded. |
dc.language.iso | eng |
dc.publisher | BMC |
dc.relation.ispartofseries | Experimental Hematology & Oncology;9 |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Sang - Malalties |
dc.subject | Hematologia oncològica |
dc.subject | COVID-19 (Malaltia) - Mortalitat |
dc.subject.mesh | Hematologic Neoplasms |
dc.subject.mesh | Coronavirus Infections |
dc.subject.mesh | /mortality |
dc.title | Risk factors and outcome of COVID-19 in patients with hematological malignancies |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1186/s40164-020-00177-z |
dc.subject.decs | neoplasias hematológicas |
dc.subject.decs | infecciones por Coronavirus |
dc.subject.decs | /mortalidad |
dc.relation.publishversion | https://doi.org/10.1186/s40164-020-00177-z |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Piñana JL] Hematology División, Hospital Universitario y Politécnico La Fe, Instituto de Investigación Sanitaria La Fe, Valencia, Spain. CIBERONC, Instituto Carlos III, Madrid, Spain. Division of Clinical Hematology, Hospital Universitario la Fe de Valencia, Avda Fernando Abril Martorell, 106 CP 46026 Valencia, Spain. [Martino R] Hematology División, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. [García-García I] Hematology División, Hospital Ramon y Cajal, Madrid, Spain. [Parody R] Hematology División, Institut Català Oncologia-Hospital Duran i Reynals, Barcelona, Spain. [Morales MD] Hematology División, Hospital de Guadalajara, Guadalajara, Spain. [Benzo G] Hematology División, Hospital La Princesa, Madrid, Spain. [Fox L] Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain |
dc.identifier.pmid | 32864192 |
dc.identifier.wos | 000566251400001 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |